Seeking better outcomes for patients
CytRx Corporation is a biopharmaceutical company focused on the discovery and development of new therapeutics to treat patients with high unmet medical needs
Latest News
CytRx has both near-term potential milestone/royalty payments and a pipeline of additional next-gen candidates

CytRx partnered Pipeline with ImmunityBio - Aldoxorubicin

Potential milestones and royalties from ImmunityBio for aldoxorubicin

CytRx milestones and royalties from Orphazyme for Arimoclomol
